Endo RF in axillary hydradenitis suppurativa

Phase 2

• Conditions: Hidradenitis suppurativa.; Hidradenitis suppurativa; L73.2

• Registration Number: IRCT20140624018210N12
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Diagnosis of suppurative hydradenitis based on the diagnosis of a dermatologist

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Qualitative severity of hidradenitis suppurativa. Timepoint: At the beginning of the study and three months later. Method of measurement: Photography and objective observation.

Secondary Outcome Measures

Name	Time	Method
Hydradenitis suppurative severity score. Timepoint: At the beginning of the study and three months later. Method of measurement: based on *Hidradenitis Suppurativa Physician'sGlobal Assessment Scale*.